Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/24/2013 | WO2013156552A1 Means and methods for generating improved proteins |
10/24/2013 | WO2013156504A1 Method for increasing the secretion of recombinant proteins |
10/24/2013 | WO2013156458A1 Reduction of formation of amidated amino acids in cell lines for protein expression |
10/24/2013 | WO2013156443A1 Method for the expression of polypeptides using modified nucleic acids |
10/24/2013 | WO2013156204A1 Solanum lycopersicum plants having non-transgenic alterations in the rin gene |
10/24/2013 | WO2013155980A1 Auto-immune disease-related microrna and use thereof |
10/24/2013 | WO2013155572A1 Cell transfection method |
10/24/2013 | WO2013155567A1 Sex determination genes |
10/24/2013 | WO2013155555A1 Peptides for the binding of nucleotide targets |
10/24/2013 | WO2013125936A3 Diagnostic test for infectious diseases in cattle |
10/24/2013 | WO2013112525A3 HERBICIDE TOLERANT COTTON EVENT pDAB4468.18.07.1 |
10/24/2013 | WO2013093648A3 Method of producing lipid nanoparticles for drug delivery |
10/24/2013 | WO2013064911A3 Single use system for sterilely producing lipid-nucleic acid particles |
10/24/2013 | WO2013009632A9 Methods of detecting hereditary cancer predisposition |
10/24/2013 | WO2012141554A8 Complex in which anti-cotinine antibody is bound to conjugate of cotinine and binding substance, and use thereof |
10/24/2013 | WO2008148010A9 Compositions comprising high concentration of biologically active molecules and processes for preparing the same |
10/24/2013 | WO2008083493A8 Stabilization of cyclic peptide structures |
10/24/2013 | WO2003052377A9 41 human secreted proteins |
10/24/2013 | WO2002079390A9 $i(pesudomonas) avr and hop proteins, their encoding nucleic acids, and use thereof |
10/24/2013 | WO2002079385A9 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
10/24/2013 | WO2002059275A9 39362, a novel human cub domain-containing protein family member and uses thereof |
10/24/2013 | WO2002059136A9 Immunoglobulin class switch recombination |
10/24/2013 | US20130283484 Salt tolerance sygt gene derived from synechocystis, and uses thereof |
10/24/2013 | US20130283483 Maize Event DP-004114-3 and Methods for Detection Thereof |
10/24/2013 | US20130283482 Stress resistant plants |
10/24/2013 | US20130283481 Composition containing gene encoding abc transporter proteins for increasing size of plant seed and content of fat stored within seed |
10/24/2013 | US20130283480 Sugar and Lipid Metabolism Regulators in Plants III |
10/24/2013 | US20130283479 Thrips resistant cabbage |
10/24/2013 | US20130283478 Plant regulatory elements and uses thereof |
10/24/2013 | US20130283477 Corn Plant Event MON87460 and Compositions and Methods for Detection Thereof |
10/24/2013 | US20130283468 Plants and seeds of corn variety cv720132 |
10/24/2013 | US20130283462 Gene conferring tobacco streak virus resistance |
10/24/2013 | US20130283461 Transgenic plants with enhanced agronomic traits |
10/24/2013 | US20130281685 iRNA AGENTS WITH BIOCLEAVABLE TETHERS |
10/24/2013 | US20130281684 Compositions and their uses directed to huntingtin |
10/24/2013 | US20130281518 Method of treating inflammatory lung disease with suppressors of cpg oligonucleotides |
10/24/2013 | US20130281516 Multicistronic expression constructs |
10/24/2013 | US20130281511 Compositions and methods for inhibiting expression of the alas1 gene |
10/24/2013 | US20130281510 siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis |
10/24/2013 | US20130281508 MicroRNA target site for cell- or tissue-specific inhibition of expression of a transgene |
10/24/2013 | US20130281382 Stable lipid-comprising drug delivery complexes and methods for their production |
10/24/2013 | US20130281324 Bi-functinal complexes and methods for making and using such complexes |
10/24/2013 | US20130281308 Methods for sorting nucleic acids and preparative in vitro cloning |
10/24/2013 | US20130280811 Plasmids and phages for homologous recombination and methods of use |
10/24/2013 | US20130280810 Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to toxic molecule |
10/24/2013 | US20130280809 Reprogramming of cells to a new fate |
10/24/2013 | US20130280806 Mammalian genes involved in infection |
10/24/2013 | US20130280793 Cell systems and methods for improving fatty acid synthesis by expression of dehydrogenases |
10/24/2013 | US20130280780 Methods and Compositions for Targeting Heterologous Integral Membrane Proteins to the Cyanobacterial Plasma Membrane |
10/24/2013 | US20130280770 Transgenic Algae with Enhanced Oil Expression |
10/24/2013 | US20130280764 Method of improving the activity of cellulase enzyme mixtures in the saccharification (ligno)cellulosic material |
10/24/2013 | US20130280735 Gene Expression Control DNA Element and Associated Protein |
10/24/2013 | US20130280727 Methods for detecting nucleic acids indicative of cancer |
10/24/2013 | US20130280368 Method for screening for diet providing production of milk having immunoregulatory action |
10/24/2013 | US20130280299 Viral vectors and their use in therapeutic methods |
10/24/2013 | US20130280258 Prognostic, diagnostic, and cancer therapeutic uses of fanci and fanci modulating agents |
10/24/2013 | US20130280222 Non-disruptive gene targeting |
10/24/2013 | US20130280221 Interleukin 15 as Selectable Marker for Gene Transfer in Lymphocytes |
10/24/2013 | US20130280220 Chimeric antigen receptor for bispecific activation and targeting of t lymphocytes |
10/24/2013 | US20130280217 Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent |
10/24/2013 | US20130280216 Methods for Use of a Specific Anti-Angiogenic Adenoviral Agent |
10/24/2013 | US20130280215 Mva vectors expressing polypeptides and having high level production in certain cell lines |
10/24/2013 | DE112012000525T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
10/23/2013 | EP2653552A1 SCREENING METHOD INDEXED USING EphA4 CLEAVAGE REACTION BY GELATINASE |
10/23/2013 | EP2653549A1 Gray leaf spot tolerant maize and methods of production |
10/23/2013 | EP2653548A1 Method for increasing the secretion of recombinant proteins |
10/23/2013 | EP2653547A2 Method for detecting methylation of the bowel-cancer-specific methylation marker gpm6a gene in order to diagnose bowel cancer |
10/23/2013 | EP2653546A2 Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis |
10/23/2013 | EP2653545A1 Methods and compositions |
10/23/2013 | EP2653544A1 Methods and compositions |
10/23/2013 | EP2653543A1 Methods and Compositions |
10/23/2013 | EP2653542A1 Methods and compositions related to mutant kunitz domain I of TFPI-2 |
10/23/2013 | EP2653541A1 Method for producing proteins |
10/23/2013 | EP2653540A1 Protein production method |
10/23/2013 | EP2653536A1 Method for preparing bacteriophages modified by the insertion of random sequences in the target proteins of said bacteriophages |
10/23/2013 | EP2653530A2 Sequencer |
10/23/2013 | EP2653529A1 Synthetic pathway constructing equipment, synthetic pathway constructing method, synthetic pathway constructing program, and processes for manufacturing 3-hydroxypropionic acid, crotonyl alcohol and butadiene |
10/23/2013 | EP2653477A1 Scorpion active peptides and preparation methods and applications thereof |
10/23/2013 | EP2653029A1 Thrips resistant cabbage |
10/23/2013 | EP2652156A1 Method of detecting resistance to cancer therapy |
10/23/2013 | EP2652152A2 Polymerization of nucleic acids using activation by polyphosphorolysis (app) reactions |
10/23/2013 | EP2652150A1 Membrane bound reporter molecules and their use in cell sorting |
10/23/2013 | EP2652139A1 Plants having increased tolerance to herbicides |
10/23/2013 | EP2652138A1 Promoters for expressing genes in a fungal cell |
10/23/2013 | EP2652137A1 Lar protein-specific ligand |
10/23/2013 | EP2652136A1 Nucleic acids targeting tctp for use in the treatment of chemo-or hormone-resistant cancers |
10/23/2013 | EP2652135A1 The abcg1 gene as a marker and a target gene for treating obesity |
10/23/2013 | EP2652134A2 Galactose cluster-pharmacokinetic modulator targeting moiety for sirna |
10/23/2013 | EP2652133A2 LIGATION METHOD EMPLOYING EUKARYOTIC tRNA LIGASE |
10/23/2013 | EP2652132A1 Multiplexed anchor scanning parallel end tag sequencing |
10/23/2013 | EP2652122A2 Method of producing succinic acid and other chemicals using sucrose-containing feedstock |
10/23/2013 | EP2651975A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
10/23/2013 | EP2651967A1 Cry1i proteins and genes for insect control |
10/23/2013 | EP2651445A2 Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications |
10/23/2013 | EP2651209A2 Soybean event syht0h2 and compositions and methods for detection thereof |
10/23/2013 | EP2651208A1 Combined use of vip3ab and cry1ab for management of resistance insects |
10/23/2013 | EP2651207A1 Methods for improving competency of plant cells |
10/23/2013 | CN203244989U Device used for performing parallel operation of mixing and extracting multiple liquid samples |
10/23/2013 | CN103370620A Diagnostic drug and diagnostic method for alzheimer's disease |
10/23/2013 | CN103370423A Classification of nucleic acid templates |